ArticleThe Lancet regional health. Western Pacific2022

A Phase 3, Multicenter, Randomized, Controlled Trial to Evaluate Immune Equivalence and Safety of Multidose and Single-dose Formulations of Vi-DT Typhoid Conjugate Vaccine in Healthy Filipino Individuals 6 Months to 45 Years of Age.

Josefina Cadorna Carlos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.